KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Sales: 2011-2025

Historic Return on Sales for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to -0.13%.

  • Dynavax Technologies' Return on Sales fell 21.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year decrease of 21.00%. This contributed to the annual value of 0.10% for FY2024, which is 13.00% up from last year.
  • Latest data reveals that Dynavax Technologies reported Return on Sales of -0.13% as of Q3 2025, which was up 21.25% from -0.17% recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Return on Sales peaked at 0.44% during Q3 2022, and registered a low of -0.24% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was 0.07% (2024), whereas its average is 0.05%.
  • In the last 5 years, Dynavax Technologies' Return on Sales soared by 333bps in 2021 and then slumped by 43bps in 2023.
  • Over the past 5 years, Dynavax Technologies' Return on Sales (Quarterly) stood at 0.22% in 2021, then increased by 19bps to 0.41% in 2022, then tumbled by 43bps to -0.03% in 2023, then climbed by 13bps to 0.10% in 2024, then declined by 21bps to -0.13% in 2025.
  • Its Return on Sales stands at -0.13% for Q3 2025, versus -0.17% for Q2 2025 and -0.20% for Q1 2025.